Back to All Companies

Genentech, Inc. | Company Profile, Marketing Contacts, Media Spend, Brands




Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs. The company is headquartered in South San Francisco, CA. ** NOTE: As a privately held subsidiary of a publicly traded parent company, annual revenue is not readily available. Therefore, the revenue figure presented below is that of the parent company. **

Main Telephone (650) 225-1000
Main Fax (650) 225-6000
Primary Address
One DNA Way
San Francisco, CA 94080-4990
USA

Genentech, Inc. Contacts

Contacts (5/30)
Name Title State
Ian C. Chief Executive Officer CA
Sample of Associated Brands
***********
Email: *****@*******.***
Main Phone: (650) 225-1000
Direct Phone: *** **** ***   ext: ****
Direct Fax: *** **** ***
Assistant Name: ** **** ***
Assistant Phone: *** **** ***
Address: One DNA Way
San Francisco, CA
94080-4990
USA

Timothy M. Senior Vice President, Global Head - Biologics Technical Operations CA
Geoff T. Vice President, Corporate Relations CA
John S. Vice President CA
Glenn B. Vice President, Quality CA

Media Spend

Media Spend Summary
Media Spend Channel

Associated Brands

Brand Media Spend
Activase *
Herceptin ****
Nutropin *
TNKase *
Genentech, Inc. ******

Agency Relationships


Brand Agency Service From To
******* ******** & ****, ***. creative unknown present
****** ***** ********* *** ********* digital 2003 present
*********, ***. *****, ***. Digital unknown present
*********, ***. ****** *** ****** mobile unknown present
*********, ***. ***** digital unknown present

See Winmo sales intelligence in action

Recent Discussions

Who is the Chief Executive Officer of Genentech, Inc.?

Who is the marketing contact for pharmaceuticals & OTC drugs in CA

What is the email of the Senior Vice President, Global Head - Biologics Technical Operations of Genentech, Inc.?

What is direct phone of the Vice President, Corporate Relations of Genentech, Inc.?

Who is the creative agency of Genentech, Inc.?

Your personal LinkedIn network connections

Your personal LinkedIn network connections

DailyVista

Genentech wins FDA approval for Avastin


The Story
Biopharmaceutical firm Genentech announced new FDA approval for its cancer drug Avastin, and decided to cap the drug's cost for lower-income patients, according to The New York Times.
 
The South San Francisco, Calif.-based company announced that Avastin just received approval to treat non-small-cell lung cancer. The drug was approved two years ago to combat colorectal cancer.
 
The treatment costs about $4,400 per month for colorectal cancer, but twice as much is needed to fight the lung cancer. The cost could send the yearly bill for lung cancer treatment to $100,000 – opening the company up to strong criticism.
 
Genentech announced a cap of $55,000 per year for all payers including health insurance companies, hospitals and private parties. Low-income patients would be eligible for free drugs or assistance with co-payments.
 
Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs.
 
The Research
Genentech can afford to implement some cost-caps.
 
In its latest quarter, Genentech’s sales of Avastin totaled $435 million, up 34 percent from the 2005 quarter.
 
Overall, the company has been growing at a tremendous pace. Genentech’s sales rose 46 percent over 2004 to $6.6 billion. Fortune just ranked them No. 79 on their annual 100 Fastest-Growing Companies list.
 
In an earlier conversation with a contact at Genentech, we learned that the company has a creative agency of record, but several firms work with the company on a project-by-project basis. We spoke to Genentech in July after the company acquired the rights to another cancer treatment (DailyVista article.)
 
According to The List database, Bedminster, N.J.-based MCS Public Relations serves as the PR agency of record for Genentech.
 
The Direction
Genentech’s a great company with a successful line of products and a healthy pipeline. The Avastin opportunities are likely all wrapped up, but agencies looking for pharmaceutical work couldn’t find a much better opportunity. We’d suggest revisiting the earlier cancer article and start building a relationship with Genentech’s executives.
 
Public relations agencies should also suggest the best way to capitalize on the price-cap angle. Big Pharma could use a little image polishing – it gets just a little more respect than Big Tobacco and Big Oil.  
Genentech, Inc.
One DNA Way
South San Francisco, CA 94080
(650) 225-1000
 
Mr. Varun Nanda
Vice President of Sales & Marketing
Avastin
(650) 225-3707
 
Debra Charlesworth
Director of Corporate Public Relations & Web Communications
(650) 225-2742